[An update on myasthenia gravis]
- PMID: 29555378
- DOI: 10.1016/j.semerg.2018.01.003
[An update on myasthenia gravis]
Abstract
Myasthenia gravis is one of the most common disorders that affect neuromuscular transmission. It is currently one of the most understood and characterised autoimmune disorders Its typical symptoms are fluctuating weakness and fatigue that affects a combination of ocular muscles, bulbar functions, as well as limb and respiratory muscles, which are due to an immune attack against the postsynaptic membrane of the neuromuscular junction. The diagnosis of myasthenia gravis is based on clinical and serological test. It is a disease that can be effectively controlled with the current therapeutic lines, even achieving a complete remission. An update of this interesting disorder is now presented.
Keywords: Acetilcolina; Acetylcholine; Autoantibodies; Autoanticuerpos; Debilidad muscular; Miastenia gravis; Muscle weakness; Myasthenia gravis.
Copyright © 2018 Sociedad Española de Médicos de Atención Primaria (SEMERGEN). Publicado por Elsevier España, S.L.U. All rights reserved.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
